Project Grant HT94252310819
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$522K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02118, USA
Similar Awards
The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
The U.S. Defense Health Agency awarded Boston Medical Center Corporation, doing business as BMC, a $3,499,453 project grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding will support the development of novel therapeutics for nephrotic syndrome, with an award period from September 15, 2023 to September 14, 2027. As a leading academic medical center and past recipient of federal research grants and contracts, BMC will leverage its...
The Defense Health Agency has awarded a $657,263 project grant under the Military Medical Research and Development program (CFDA 12.420) to the Dana-Farber Cancer Institute, Inc. (d.b.a. DFCI) in Boston, MA. The award, effective September 1, 2024 through August 31, 2027, will support DATA-DRIVEN BIOMARKER-INFORMED DECISION ANALYTICS IN MELANOMA: IMPROVING EFFICACY AND REDUCING TOXICITY OF IMMUNE CHECKPOINT BLOCKADE. Through this grant, DFCI will conduct research to develop data-driven...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,635,000 Project Grant to the Trustees of Boston University's Medical Campus on April 1, 2025. The grant supports advanced biomedical research on the "CIRCULAR RNA REPERTOIRE REGULATES HOST DEFENSE AGAINST BACTERIAL SEPSIS AND LUNG INJURY". The research will be conducted at Boston University's facilities in Boston, MA and is expected to be completed by March 31, 2029. As a leading...
The Defense Health Agency has awarded a $1,780,000 Project Grant titled "SUPPORTING UNDERREPRESENTED POPULATIONS IN GENOMICS-BASED CANCER TRIAL ENROLLMENT (SURGE)" to the Dana-Farber Cancer Institute, Inc. in Boston, MA. This award, funded through the Military Medical Research and Development program (CFDA 12.420), will support cancer research focused on improving enrollment of underrepresented populations in genomics-based clinical trials. The grant period runs from July 1, 2024 to...
The federal Project Grant award of $268,000.00 from the Defense Health Agency's Military Medical Research and Development (CFDA 12.420) program supports the development of "PDAC-PATHWAYS: A DIGITAL INFORMATIONAL AND SUPPORTIVE CARE APP FOR PATIENTS INITIATING NEOADJUVANT THERAPY FOR PANCREATIC DUCTAL ADENOCARCINOMA". The award, effective from September 1, 2025 through August 31, 2027, was granted to The General Hospital Corporation, doing business as Massachusetts General Hospital, a...
The U.S. Defense Health Agency awarded a $888,632 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The General Hospital Corporation (doing business as Massachusetts General Hospital) in Boston, MA. The grant, which runs from April 1, 2025 to March 31, 2027, supports research to decipher the role of maternal autoantibodies in inducing behavioral abnormalities in offspring following maternal Toll-like receptor 7 (TLR7) activation. The research aims to...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $330,000 project grant to Trustees of Boston University, doing business as the Boston University Medical Campus. The grant, awarded on March 15, 2024, will fund research to enhance lymphatic function using transplanted muscle cells after bacterial infection. The research aims to improve medical care for military service members, veterans, and their families. Boston University, a leading...
This federal Project Grant award of $518,700.00 was made by the Defense Health Agency on July 1, 2024 to the Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, MA. The award is part of the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research initiatives to improve health outcomes for military service members, veterans, and the broader public. The funding will support Bidmc's project titled "EXPLOITING DISRUPTION IN TRANSCRIPTIONAL...
The Department of Defense's Defense Health Agency has awarded a $1,258,719 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant, awarded on July 15, 2024, will support a 3-year research project titled "Melanoma Chemoprevention via Neuropilin-2 Axis Blockade." Through this grant, Boston Children's Hospital will conduct biomedical research focused on...